These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 21907187)

  • 1. Lovastatin inhibits proliferation of anaplastic thyroid cancer cells through up-regulation of p27 by interfering with the Rho/ROCK-mediated pathway.
    Zhong WB; Hsu SP; Ho PY; Liang YC; Chang TC; Lee WS
    Biochem Pharmacol; 2011 Dec; 82(11):1663-72. PubMed ID: 21907187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA/ROCK signaling.
    Zhong WB; Liang YC; Wang CY; Chang TC; Lee WS
    Endocr Relat Cancer; 2005 Sep; 12(3):615-29. PubMed ID: 16172195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas.
    Motti ML; Califano D; Baldassarre G; Celetti A; Merolla F; Forzati F; Napolitano M; Tavernise B; Fusco A; Viglietto G
    Carcinogenesis; 2005 Jun; 26(6):1021-34. PubMed ID: 15718252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin Inhibits Cell Proliferation and Migration in Human Anaplastic Thyroid Cancer.
    Chen MC; Tsai YC; Tseng JH; Liou JJ; Horng S; Wen HC; Fan YC; Zhong WB; Hsu SP
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29236027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lovastatin induces apoptosis of anaplastic thyroid cancer cells via inhibition of protein geranylgeranylation and de novo protein synthesis.
    Zhong WB; Wang CY; Chang TC; Lee WS
    Endocrinology; 2003 Sep; 144(9):3852-9. PubMed ID: 12933658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanism of cell cycle blockage of hepatoma SK-Hep-1 cells by Epimedin C through suppression of mitogen-activated protein kinase activation and increased expression of CDK inhibitors p21(Cip1) and p27(Kip1).
    Liu TZ; Chen CY; Yiin SJ; Chen CH; Cheng JT; Shih MK; Wang YS; Chern CL
    Food Chem Toxicol; 2006 Feb; 44(2):227-35. PubMed ID: 16112786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p27-Associated G1 arrest induced by hinokitiol in human malignant melanoma cells is mediated via down-regulation of pRb, Skp2 ubiquitin ligase, and impairment of Cdk2 function.
    Liu S; Yamauchi H
    Cancer Lett; 2009 Dec; 286(2):240-9. PubMed ID: 19631451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mevastatin can cause G1 arrest and induce apoptosis in pulmonary artery smooth muscle cells through a p27Kip1-independent pathway.
    Fouty BW; Rodman DM
    Circ Res; 2003 Mar; 92(5):501-9. PubMed ID: 12600884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lovastatin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion.
    Gray-Bablin J; Rao S; Keyomarsi K
    Cancer Res; 1997 Feb; 57(4):604-9. PubMed ID: 9044834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lovastatin-induced inhibition of HL-60 cell proliferation via cell cycle arrest and apoptosis.
    Park WH; Lee YY; Kim ES; Seol JG; Jung CW; Lee CC; Kim BK
    Anticancer Res; 1999; 19(4B):3133-40. PubMed ID: 10652602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis.
    Park WH; Seol JG; Kim ES; Hyun JM; Jung CW; Lee CC; Kim BK; Lee YY
    Cancer Res; 2000 Jun; 60(11):3065-71. PubMed ID: 10850458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
    Arita Y; Buffolino P; Coppock DL
    Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho/ROCK signaling in regulation of corneal epithelial cell cycle progression.
    Chen J; Guerriero E; Lathrop K; SundarRaj N
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):175-83. PubMed ID: 18172090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation.
    Lee MH; Cho YS; Han YM
    Stem Cells; 2007 Jul; 25(7):1654-63. PubMed ID: 17464088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line.
    Ghosh PM; Ghosh-Choudhury N; Moyer ML; Mott GE; Thomas CA; Foster BA; Greenberg NM; Kreisberg JI
    Oncogene; 1999 Jul; 18(28):4120-30. PubMed ID: 10435593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin inhibits growth via apoptosis and the induction of cell cycle arrest in human melanoma cells.
    Saito A; Saito N; Mol W; Furukawa H; Tsutsumida A; Oyama A; Sekido M; Sasaki S; Yamamoto Y
    Melanoma Res; 2008 Apr; 18(2):85-94. PubMed ID: 18337644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes.
    Assmus B; Urbich C; Aicher A; Hofmann WK; Haendeler J; Rössig L; Spyridopoulos I; Zeiher AM; Dimmeler S
    Circ Res; 2003 May; 92(9):1049-55. PubMed ID: 12676819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin induces apoptosis and cell growth arrest in prostate cancer cells.
    Hoque A; Chen H; Xu XC
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):88-94. PubMed ID: 18199714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy.
    Danesh FR; Sadeghi MM; Amro N; Philips C; Zeng L; Lin S; Sahai A; Kanwar YS
    Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8301-5. PubMed ID: 12048257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMG-CoA reductase inhibitor simvastatin overcomes bortezomib-induced apoptosis resistance by disrupting a geranylgeranyl pyrophosphate-dependent survival pathway.
    Fuchs D; Berges C; Opelz G; Daniel V; Naujokat C
    Biochem Biophys Res Commun; 2008 Sep; 374(2):309-14. PubMed ID: 18625202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.